Pearl Drugs Private Limited - Company Profile

It is a chemicals private limited company based in Ahmedabad, Gujarat, India, established in 2000.
2000 Ahmedabad, Gujarat, India Struck Off
Last Updated:
Access Report
About Pearl Drugs Private Limited

Pearl Drugs Private Limited, a struck off private limited company, was established on 27 April 2000 in Ahmedabad, Gujarat, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232GJ2000PTC037876. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.40 M.

Its leadership includes Jayesh Kanaiyalal Shukla (Director), Shailesh Ramprasad Chaturvedi (Director). Past directors included Padma Dayaldas Panjvani, Bhagyesh Govindlal Trivedi. Its latest AGM occurred on 29 September 2013, with the balance sheet filed on 31 March 2013. It is based at 24, Royal Cresent, Nr. Thaltej Char Rasta, Thaltej,, Ahmedabad, Gujarat, 380054.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232GJ2000PTC037876

  • Registration Number

    037876

  • Incorporation Date

    27 April 2000

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.40 M

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.40 M
  • Company Age 25 Year, 11 Months
  • Last Filing with ROC 31 Mar 2013
Company report

Pearl Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Pearl Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Pearl Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Jayesh Kanaiyalal Shukla Director 01 Oct 2005 Current
Shailesh Ramprasad Chaturvedi Director 01 Oct 2005 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 01 Sep 2007 Past
Pramod Abcsdd Director 01 Sep 2007 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Pearl Drugs.

Enhance accessibility to Pearl Drugs's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Pearl Drugs revenue growth over time
Pearl Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Pearl Drugs?

Unlock access to Pearl Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Pearl Drugs?

Unlock and access historical data on people associated with Pearl Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Pearl Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pearl Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Pearl Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Pearl Drugs Private Limited last Annual general meeting of members was held on 29 Sep 2013 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Pearl Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Ahmedabad. was documented.

  • Director Appointment

    Jayesh Kanaiyalal Shukla was appointed as a Director was appointed as a Director on 01 Oct 2005 & has been associated with this company since 20 years 5 months . was recorded as a recent event.

  • Director Appointment

    The activity Shailesh Ramprasad Chaturvedi was appointed as a Director was appointed as a Director on 01 Oct 2005 & has been associated with this company since 20 years 5 months . was completed.

  • Company Incorporation

    Pearl Drugs Private Limited was registered on 27 Apr 2000 with Roc Ahmedabad & aged 25 years 11 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Pearl Drugs Private Limited?

The CIN of Pearl Drugs Private Limited is U24232GJ2000PTC037876.

Where is Pearl Drugs Private Limited headquartered?

Pearl Drugs Private Limited is headquartered at 24, Royal Cresent, Nr. Thaltej Char Rasta, Thaltej,, Ahmedabad, Gujarat, 380054.

When was Pearl Drugs Private Limited incorporated?

Pearl Drugs Private Limited was incorporated on 27 April 2000.

Who are the current directors of Pearl Drugs Private Limited?

The current directors of Pearl Drugs Private Limited are

What is the primary industry of Pearl Drugs Private Limited?

The primary industry of Pearl Drugs Private Limited is Chemicals.

Is Pearl Drugs Private Limited a listed company?

Pearl Drugs Private Limited is unlisted.

What is the capital structure of Pearl Drugs Private Limited?

The authorized capital of Pearl Drugs Private Limited is ₹1.00 M, and the paid-up capital is ₹0.40 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available